This is the first study assessing saliva oxytocin and IL-1β concentrations along with score-based assessment of clinical responsiveness [head pain severity, frequency (headache days-attacks/month), functional state (sleep quality, mood, quality of life)] in migraine patients treated with adjunctive cervical nVNS. Here, OXT is linked to migraine disorder.